Products for Research Use Only
RegisterLogin

ZPCK

CAT: 0804-HY-100709-01Size: 100 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-100709-01Size:100 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
ZPCK is an oral active proagent of gemcitabine that was designed for improved oral bioavailability[1].
CAS Number
26049-94-5
Product Name Alternative
SL-01
UNSPSC
12352005
Hazard Statement
H314
Target
Apoptosis; Autophagy; DNA/RNA Synthesis; Nucleoside Antimetabolite/Analog
Type
Reference compound
Related Pathways
Apoptosis; Autophagy; Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/zpck.html
Purity
99.0
Solubility
DMSO : 33 mg/mL (ultrasonic; warming)
Smiles
O=C(OCC1=CC=CC=C1)N[C@@H](CC2=CC=CC=C2)C(CCl)=O
Molecular Formula
C18H18ClNO3
Molecular Weight
331.79
Precautions
H314
References & Citations
[1]Zhao C, et al. Pharmacokinetics and metabolism of SL-01, a prodrug of gemcitabine, in rats. Cancer Chemother Pharmacol. 2013 Jun;71 (6) :1541-50.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Alternative Products

CatalogName
MBS3603791-01ZPCK
SIH-343-50MGZPCK (SL-01)
MBS6084808-01SL-01, p53/MDM2 Inhibitor (N-Benzyloxycarbonyl-Lphenylalaninylchloromethyl ketone, ZPCK)

Popular Products